Owlstone partners with Bicycle Therapeutics to develop antigen-targeted EVOC Probes for early cancer detection
Owlstone Medical, the global leader in Breath Biopsy for applications in early disease detection and precision medicine, has entered into a Research Agreement with Bicycle Therapeutics, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology.